Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory T cells
Biotech
Coya shares data on IL-2 prospect in small Alzheimer's study
Coya put the asset on the back burner last year but said the data boost its confidence in pursuing partnerships and studying drug combinations.
Nick Paul Taylor
Oct 29, 2024 7:55am
REGiMMUNE, Kiji merge to create Treg 'super company,' plan IPO
Oct 18, 2024 8:05am
AstraZeneca pays $85M to Quell diabetes with 'one and done' drug
Jun 9, 2023 2:00am
Lilly pays $55M to ride TRex into regulatory T-cell space
Jan 9, 2023 9:10am
Islet-homing engineered T regs protect against Type 1 diabetes
Oct 10, 2022 9:57am
Next-gen CAR player Quell Therapeutics drives into the fast lane
Nov 29, 2021 7:15am
